Patents/Assignees

Takeda Pharmaceutical Company Limited

256 patents in portfolio

US12433907utility2025
Use of Maribavir in Treatment Regimens
0 cites
US12435063utility2025
Nitrogen Containing Heterocycles as CDK12 Inhibitors
0 cites
US12428615utility2025
Matrix Composition
0 cites
US12428403utility2025
N-(heterocyclyl and Heterocyclylalkyl)-3-benzylpyridin-2-amine Derivatives as SSTR4 Agonists
0 cites
US12419890utility2025
Administration of Sumo-activating Enzyme Inhibitor and Checkpoint Inhibitors
0 cites
US12421188utility2025
Heterocyclic Compound and Use Thereof
0 cites
US12415782utility2025
Heterocyclic Compound and Use Thereof
0 cites
US12415866utility2025
Monoclonal Antibody Inhibitor of Factor Xiia
0 cites
US12409210utility2025
CNS Delivery of Therapeutic Agents
0 cites
US12404237utility2025
Method of Treating Excessive Sleepiness And/or Cataplexy Using N-{2-(([1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide Derivatives
0 cites
US12403154utility2025
Administration of Sting Agonist and Checkpoint Inhibitors
0 cites
US12391760utility2025
Method of Treating Primary Sclerosing Cholangitis
0 cites
US12391739utility2025
Method for Producing Gamma Delta T Cells
0 cites
US12391765utility2025
Methods and Materials for Assessing Response to Plasmablast- and Plasma Cell-depleting Therapies
0 cites
US12383587utility2025
AAV Triple-plasmid System
0 cites
US12384770utility2025
Heterocyclic Compound
0 cites
US12384854utility2025
Plasma Kallikrein Binding Proteins and Uses Thereof in Treating Hereditary Angioedema
0 cites
USD1087117design2025
Display Screen or Portion Thereof with a Graphical User Interface
0 cites
US12378256utility2025
Heterocyclic Compound
0 cites
US12377078utility2025
Viral Inhibitors, the Synthesis Thereof, and Intermediates Thereto
0 cites

← PreviousPage 3 of 13Next →